Pregnancy outcomes following exposure to onabotulinumtoxinA

Trial Profile

Pregnancy outcomes following exposure to onabotulinumtoxinA

Completed
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 09 Dec 2015

At a glance

  • Drugs Botulinum toxin A (Primary)
  • Indications Hyperhidrosis; Migraine; Movement disorders; Muscle spasticity; Neurogenic bladder; Skin wrinkles
  • Focus Adverse reactions
  • Sponsors Allergan
  • Most Recent Events

    • 09 Dec 2015 New trial record
    • 04 Dec 2015 Results published in the Pharmacoepidemiology and Drug Safety
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top